Stock 603520 ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Starry Pharmaceutical Co.,Ltd.

Equities

603520

CNE1000026N8

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
11.87 CNY +0.17% Intraday chart for Zhejiang Starry Pharmaceutical Co.,Ltd. +9.00% -15.70%
2023 Zhejiang Starry Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
2023 Zhejiang Starry Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Zhejiang Starry Pharmaceutical Co., Ltd. is principally engaged in the research and development (R&D), production and sales of X-ray contrast medium, quinolone antimicrobial agents and other drugs' pharmaceutical raw materials and intermediates. The X-ray contrast medium's major product is iohexol active pharmaceutical ingredient. Quinolone antimicrobial agents' major products are levofloxacin hydrochloride active pharmaceutical ingredient and levofloxacin hemihydrates active pharmaceutical ingredient.

Number of employees: 1,842

Sales per Business

CNY in Million2021Weight2022Weight Delta
Contrast Agent
82.2 %
1,743 87.2 % 1,753 82.2 % +0.56%
Other Business
12.4 %
127 6.3 % 264 12.4 % +108.06%
Quinolone
2.5 %
36 1.8 % 54 2.5 % +50.81%
CDMO
2.4 %
- - 52 2.4 % -
Others
0.4 %
95 4.7 % 9 0.4 % -90.09%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
62.9 %
1,263 67.4 % 1,176 62.9 % -6.92%
Abroad
37.1 %
610 32.6 % 692 37.1 % +13.41%

Managers

Managers TitleAgeSince
Wei Yi Shen CEO
 Chief Executive Officer 44 09-08-31
Jun Feng Guo DFI
 Director of Finance/CFO 39 22-12-25
Jian Hu CHM
 Chairman 45 10-12-31
Jin Sheng Hu BRD
 Director/Board Member 69 03-12-31
Chao Sun SEC
 Corporate Secretary 37 20-03-31

Members of the board

Members of the board TitleAgeSince
Hong Fei Zhang BRD
 Director/Board Member 45 23-05-08
Mei Ying Mao BRD
 Director/Board Member 61 23-05-08
Jin Sheng Hu BRD
 Director/Board Member 69 03-12-31
Jian Hu CHM
 Chairman 45 10-12-31
Fang Wei Zhang CHM
 Chairman 46 04-12-31
Ling Qiao Li BRD
 Director/Board Member 45 20-04-26
Wei Yi Shen CEO
 Chief Executive Officer 44 09-08-31
Gang Xu BRD
 Director/Board Member - 23-05-08
Xiao Ke Zhang BRD
 Director/Board Member 46 23-05-08
Ji Ming Hu BRD
 Director/Board Member 50 23-05-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 342,514,501 212,464,603 ( 62.03 %) 0 62.03 %

Shareholders

NameEquities%Valuation
Jin Sheng Hu
19.56 %
66,954,456 19.56 % 112 M ¥
Jian Hu
18.04 %
61,740,000 18.04 % 103 M ¥
Rongtong Fund Management Co., Ltd.
3.378 %
11,562,970 3.378 % 19 M ¥
Taizhou Juhe Investment Co. Ltd.
2.380 %
8,148,000 2.380 % 14 M ¥
Caitong Securities Asset Management Co., Ltd.
1.023 %
3,500,000 1.023 % 6 M ¥
Wanjia Asset Management Co., Ltd.
0.8392 %
2,872,540 0.8392 % 5 M ¥
Galaxy Asset Management Co., Ltd.
0.6980 %
2,389,040 0.6980 % 4 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
0.6591 %
2,255,990 0.6591 % 4 M ¥
China Resources SZITIC Trust Co., Ltd.
0.5128 %
1,755,420 0.5128 % 3 M ¥
Yinhua Fund Management Co., Ltd.
0.5074 %
1,736,819 0.5074 % 3 M ¥

Company contact information

Zhejiang Starry Pharmaceutical Co., Ltd.

9 Fengxi West Road Modern Industrial Cluster Zone

317306, Taizhou

+

http://www.starrypharm.com
address Zhejiang Starry Pharmaceutical Co.,Ltd.(603520)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Zhejiang Starry Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.87
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD. Stock Zhejiang Starry Pharmaceutical Co.,Ltd.
-15.70% 561M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603520 Stock
  4. Company Zhejiang Starry Pharmaceutical Co.,Ltd.